Komori
Muromachi Chemicals (4885) · TargetFirst stated

Use of Proceeds for the Installation of Pharmaceutical Manufacturing Equipment and Repayment of Borrowings

First written in FY2021-Q3. . Latest entry: FY2021-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Public Offering and Third-Party Allotment Capital Increase to Fund Capital Investment and Debt RepaymentA theme 92 companies write about · 1 as a headwind · 96 as a tailwind

11 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 92 companies compared. The sentences above are computed from all 92.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q3First statedAnnual report

    「Use of funds: together with the net proceeds from the public offering of shares, the funds are scheduled to be allocated to (1) the cost of installing pharmaceutical manufacturing equipment and (2) repayment of borrowings.」

    The net proceeds from the public offering and private placement are scheduled to be used for the installation of pharmaceutical manufacturing equipment and repayment of borrowings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Muromachi Chemicals yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Use of Proceeds for the Installation of Pharmaceutical Manufacturing Equipment and Repayment of Borrowings | MUROMACHI CHEMICALS INC. (4885) | Komori